Minocycline markedly reduces acute visceral nociception via inhibiting neuronal ERK phosphorylation

Molecular Pain

Volumn 8, Issue , 2012, Pages

  Cho, Ik Hyun ^a   Lee, Min Jung ^a   Jang, Minhee ^a   Gwak, Nam Gil ^a   Lee, Ka Yeon ^a   Jung, Hyuk Sang ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Acute visceral pain; C Fos; Minocycline; P ERK; Writhes

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MINOCYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN C FOS;

ABDOMINAL PAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VISCERAL PAIN; WRITHING TEST; ANIMAL; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; NOCICEPTION; PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED ICR; MINOCYCLINE; NOCICEPTION; PHOSPHORYLATION; VISCERAL PAIN;

EID: 84862784235     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-8-13     Document Type: Article

References (72)

1. Aronson AL. Pharmacotherapeutics of the newer tetracyclines. J Am Vet Med Assoc 1980, 176(10):1061-1068.
2. Thomas M, Le WD. Minocycline: neuroprotective mechanisms in Parkinson's disease. Curr Pharm Des 2004, 10(6):679-686. 10.2174/1381612043453162, 14965330.
3. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 1998, 95(26):15769-15774. 10.1073/pnas.95.26.15769, 28119, 9861045.
4. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 1999, 96(23):13496-500. 10.1073/pnas.96.23.13496, 23976, 10557349.
5. Wells JE, Hurlbert RJ, Fehlings MG, Yong VW. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain 2003, 126(Pt 7):1628-1637.
6. Tikka TM, Koistinaho JE. Minocycline provides neuroprotection against N-methyl-Daspartate neurotoxicity by inhibiting microglia. J Immunol 2001, 166(12):7527-7533.
7. Brundula V, Rewcastle NB, Metz LM, Bernard CC, Yong VW. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis. Brain 2002, 125(Pt 6):1297-1308.
8. Bantubungi K, Jacquard C, Greco A, Pintor A, Chtarto A, Tai K, Galas MC, Tenenbaum L, Deglon N, Popoli P, Minghetti L, Brouillet E, Brotchi J, Levivier M, Schiffmann SN, Blum D. Minocycline in phenotypic models of Huntington's disease. Neurobiol Dis 2005, 18(1):206-217. 10.1016/j.nbd.2004.09.017, 15649711.
9. He Y, Appel S, Le W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res 2001, 909(1-2):187-193. 10.1016/S0006-8993(01)02681-6, 11478935.
10. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi DK, Ischiropoulos H, Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 2002, 22(5):1763-1771.
11. Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, Watkins LR. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 2005, 115(1-2):71-83. 10.1016/j.pain.2005.02.009, 15836971.
12. Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 2003, 306(2):624-630. 10.1124/jpet.103.052407, 12734393.
13. Morgado C, Pereira-Terra P, Cruz CD, Tavares I. Minocycline completely reverses mechanical hyperalgesia in diabetic rats through microglia-induced changes in the expression of the potassium chloride co-transporter 2 (KCC2) at the spinal cord. Diabetes Obes Metab 2011, 13(2):150-159. 10.1111/j.1463-1326.2010.01333.x, 21199267.
14. Piao ZG, Cho IH, Park CK, Hong JP, Choi SY, Lee SJ, Lee S, Park K, Kim JS, Oh SB. Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury. Pain 2006, 121(3):219-231. 10.1016/j.pain.2005.12.023, 16495005.
15. Cho IH, Chung YM, Park CK, Park SH, Li HY, Kim D, Piao ZG, Choi SY, Lee SJ, Park K, Kim JS, Jung SJ, Oh SB. Systemic administration of minocycline inhibits formalininduced inflammatory pain in rat. Brain Res 2006, 1072(1):208-214. 10.1016/j.brainres.2005.12.039, 16427032.
16. Cervero F, Laird JM. Visceral pain. Lancet 1999, 353(9170):2145-2148. 10.1016/S0140-6736(99)01306-9, 10382712.
17. Knowles CH, Aziz Q. Basic and clinical aspects of gastrointestinal pain. Pain 2009, 141(3):191-209. 10.1016/j.pain.2008.12.011, 19155134.
18. Larauche M, Mulak A, Taché Y. Stress and visceral pain: From animal models to clinical therapies. Exp Neurol
19. Galan A, Cervero F, Laird JM. Extracellular signaling-regulated kinase-1 and -2 (ERK 1/2) mediate referred hyperalgesia in a murine model of visceral pain. Brain Res Mol Brain Res 2003, 116(1-2):126-134.
20. Lai HH, Qiu CS, Crock LW, Morales ME, Ness TJ, Gereau RW. Activation of spinal extracellular signal-regulated kinases (ERK) 1/2 is associated with the development of visceral hyperalgesia of the bladder. Pain 2011, 152(9):2117-2124. 10.1016/j.pain.2011.05.017, 21705143.
21. Ji RR, Baba H, Brenner GJ, Woolf CJ. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci 1999, 2(12):1114-1119. 10.1038/16040, 10570489.
22. Ji RR, Befort K, Brenner GJ, Woolf CJ. ERK MAP kinase activation in superficial spinal cord neurons induces prodynorphin and NK-1 upregulation and contributes to persistent inflammatory pain hypersensitivity. J Neurosci 2002, 22(2):478-485.
23. Ma W, Quirion R. The ERK/MAPK pathway, as a target for the treatment of neuropathic pain. Expert Opin Ther Targets 2005, 9(4):699-713. 10.1517/14728222.9.4.699, 16083338.
24. Qiao LY, Gulick MA. Region-specific changes in the phosphorylation of ERK1/2 and ERK5 in rat micturition pathways following cyclophosphamide-induced cystitis. Am J Physiol Regul Integr Comp Physiol 2007, 292(3):R1368-1375.
25. Hunt SP, Pini A, Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987, 328(6131):632-634. 10.1038/328632a0, 3112583.
26. Zhang XJ, Li Z, Chung EK, Zhang HQ, Xu HX, Sung JJ, Bian ZX. Activation of extracellular signal-regulated protein kinase is associated with colorectal distension-induced spinal and supraspinal neuronal response and neonatal maternal separation-induced visceral hyperalgesia in rats. J Mol Neurosci 2009, 37(3):274-287. 10.1007/s12031-008-9134-y, 18649147.
27. Seino D, Tokunaga A, Tachibana T, Yoshiya S, Dai Y, Obata K, Yamanaka H, Kobayashi K, Noguchi K. The role of ERK signaling and the P2X receptor on mechanical pain evoked by movement of inflamed knee joint. Pain 2006, 123(1-2):193-203. 10.1016/j.pain.2006.02.032, 16616417.
28. Mogil JS, Wilson SG, Bon K, Lee SE, Chung K, Raber P, Pieper JO, Hain HS, Belknap JK, Hubert L, Elmer GI, Chung JM, Devor M. Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception. Pain 1999, 80(1-2):67-82. 10.1016/S0304-3959(98)00197-3, 10204719.
29. De Leo JA, Coombs DW, McCarthy LE. Differential c-fos-like protein expression in mechanically versus chemically induced visceral nociception. Brain Res Mol Brain Res 1991, 11(2):167-170.
30. Herdegen T, Kovary K, Leah J, Bravo R. Specific temporal and spatial distribution of JUN, FOS, and KROX-24 proteins in spinal neurons following noxious transsynaptic stimulation. J Comp Neurol 1991, 313(1):178-191. 10.1002/cne.903130113, 1761754.
31. Al-Chaer ED, Traub RJ. Biological basis of visceral pain: recent developments. Pain 2002, 96(3):221-225. 10.1016/S0304-3959(02)00046-5, 11972993.
32. Svensson CI, Marsala M, Westerlund A, Calcutt NA, Campana WM, Freshwater JD, Catalano R, Feng Y, Protter AA, Scott B, Yaksh TL. Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing. J Neurochem 2003, 86(6):1534-1544. 10.1046/j.1471-4159.2003.01969.x, 12950462.
33. Fu KY, Light AR, Matsushima GK, Maixner W. Microglial reactions after subcutaneous formalin injection into the rat hind paw. Brain Res 1999, 825(1-2):59-67. 10.1016/S0006-8993(99)01186-5, 10216173.
34. Garrison CJ, Dougherty PM, Kajander KC, Carlton SM. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 1991, 565(1):1-7. 10.1016/0006-8993(91)91729-K, 1723019.
35. Coyle DE. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Glia 1998, 23(1):75-83. 10.1002/(SICI)1098-1136(199805)23:1<75::AID-GLIA7>3.0.CO;2-3, 9562186.
36. Nakagawa T, Kaneko S. Spinal astrocytes as therapeutic targets for pathological pain. J Pharmacol Sci 2010, 114(4):347-353. 10.1254/jphs.10R04CP, 21081837.
37. Hong J, Cho IH, Kwak KI, Suh EC, Seo J, Min HJ, Choi SY, Kim CH, Park SH, Jo EK, Lee S, Lee KE, Lee SJ. Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death. J Biol Chem 2010, 285(50):39447-39457. 10.1074/jbc.M110.132522, 2998094, 20923777.
38. Koster R, Anderson M, de Beer EJ. Acetic acid for analgesic screening. Fed Proc 1959, 18:412.
39. Bonaz B, Rivière PJ, Sinniger V, Pascaud X, Junien JL, Fournet J, Feuerstein C. Fedotozine, a kappa-opioid agonist, prevents spinal and supra-spinal Fos expression induced by a noxious visceral stimulus in the rat. Neurogastroenterol Motil 2000, 12(2):135-147. 10.1046/j.1365-2982.2000.00188.x, 10771495.
40. Deyama S, Nakagawa T, Kaneko S, Uehara T, Minami M. Involvement of the bed nucleus of the stria terminalis in the negative affective component of visceral and somatic pain in rats. Behav Brain Res 2007, 176(2):367-371. 10.1016/j.bbr.2006.10.021, 17101179.
41. Hammond DL, Presley R, Gogas KR, Basbaum AI. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat. J Comp Neurol 1992, 315(2):244-253. 10.1002/cne.903150210, 1545011.
42. Martínez V, Thakur S, Mogil JS, Taché Y, Mayer EA. Differential effects of chemical and mechanical colonic irritation on behavioral pain response to intraperitoneal acetic acid in mice. Pain 1999, 81(1-2):179-186. 10.1016/S0304-3959(99)00008-1, 10353506.
43. Nikai T, Basbaum AI, Ahn AH. Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti-migraine drug, sumatriptan. Pain 2008, 139(3):533-540. 10.1016/j.pain.2008.06.002, 2869302, 18723285.
44. Reichert JA, Daughters RS, Rivard R, Simone DA. Peripheral and preemptive opioid antinociception in a mouse visceral pain model. Pain 2001, 89(2-3):221-227. 10.1016/S0304-3959(00)00365-1, 11166478.
45. Friese N, Chevalier E, Angel F, Pascaud X, Junien JL, Dahl SG, Riviere PJ. Reversal by kappa-agonists of peritoneal irritation-induced ileus and visceral pain in rats. Life Sci 1997, 60(9):625-634. 10.1016/S0024-3205(96)00647-9, 9048965.
46. Livingston EH, Passaro EP. Postoperative ileus. Dig Dis Sci 1990, 35(1):121-132. 10.1007/BF01537233, 2403907.
47. Pairet M, Ruckebusch Y. On the relevance of non-steroidal anti-inflammatory drugs in the prevention of paralytic ileus in rodents. J Pharm Pharmacol 1989, 41(11):757-761.
48. Ghia JE, Crenner F, Metz-Boutigue MH, Aunis D, Angel F. The effect of a chromogranin A-derived peptide (CgA4-16) in the writhing nociceptive response induced by acetic acid in rats. Life Sci 2004, 75(15):1787-1799. 10.1016/j.lfs.2004.02.035, 15302224.
49. Sinniger V, Porcher C, Mouchet P, Juhem A, Bonaz B. c-fos and CRF receptor gene transcription in the brain of acetic acid-induced somato-visceral pain in rats. Pain 2004, 110(3):738-750. 10.1016/j.pain.2004.05.014, 15288415.
50. Bastos LF, Merlo LA, Rocha LT, Coelho MM. Characterization of the antinociceptive and anti-inflammatory activities of doxycycline and minocycline in different experimental models. Eur J Pharmacol 2007, 576(1-3):171-179. 10.1016/j.ejphar.2007.07.049, 17719028.
51. Padi SS, Kulkarni SK. Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms. Eur J Pharmacol 2008, 601(1-3):79-87. 10.1016/j.ejphar.2008.10.018, 18952075.
52. De Leo JA, Tawfik VL, LaCroix-Fralish ML. The tetrapartite synapse: path to CNS sensitization and chronic pain. Pain 2006, 122(1-2):17-21. 10.1016/j.pain.2006.02.034, 16564626.
53. Curran T, Morgan JI. Fos: an immediate-early transcription factor in neurons. J Neurobiol 1995, 26(3):403-412. 10.1002/neu.480260312, 7775973.
54. Vergnolle N, Bunnett NW, Sharkey KA, Brussee V, Compton SJ, Grady EF, Cirino G, Gerard N, Basbaum AI, Andrade-Gordon P, Hollenberg MD, Wallace JL. Proteinaseactivated receptor-2 and hyperalgesia: A novel pain pathway. Nat Med 2001, 7(7):821-826. 10.1038/89945, 11433347.
55. Huang X, Yang J, Chang JK, Dun NJ. Amylin suppresses acetic acid-induced visceral pain and spinal c-fos expression in the mouse. Neuroscience 2010, 165(4):1429-1438. 10.1016/j.neuroscience.2009.11.063, 2815112, 19958820.
56. Kawasaki Y, Kohno T, Zhuang ZY, Brenner GJ, Wang H, Van Der Meer C, Befort K, Woolf CJ, Ji RR. Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. J Neurosci 2004, 24(38):8310-8321. 10.1523/JNEUROSCI.2396-04.2004, 15385614.
57. Song XS, Cao JL, Xu YB, He JH, Zhang LC, Zeng YM. Activation of ERK/CREB pathway in spinal cord contributes to chronic constrictive injury-induced neuropathic pain in rats. Acta Pharmacol Sin 2005, 26(7):789-798. 10.1111/j.1745-7254.2005.00123.x, 15960884.
58. Cruz CD, Ferreira D, McMahon SB, Cruz F. The activation of the ERK pathway contributes to the spinal c-fos expression observed after noxious bladder stimulation. Somatosens Mot Res 2007, 24(1-2):15-20. 10.1080/08990220601143265, 17558919.
59. Karim F, Wang CC, Gereau RW. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci 2001, 21(11):3771-3779.
60. Pezet S, Malcangio M, Lever IJ, Perkinton MS, Thompson SW, Williams RJ, McMahon SB. Noxious stimulation induces Trk receptor and downstream ERK phosphorylation in spinal dorsal horn. Mol Cell Neurosci 2002, 21(4):684-695. 10.1006/mcne.2002.1205, 12504600.
61. Million M, Wang L, Wang Y, Adelson DW, Yuan PQ, Maillot C, Coutinho SV, Mcroberts JA, Bayati A, Mattsson H, Wu V, Wei JY, Rivier J, Vale W, Mayer EA, Taché Y. CRF2 receptor activation prevents colorectal distension induced visceral pain and spinal ERK1/2 phosphorylation in rats. Gut 2006, 55(2):172-181. 10.1136/gut.2004.051391, 1856510, 15985561.
62. Cao H, Zhang YQ. Spinal glial activation contributes to pathological pain states. Neurosci Biobehav Rev 2008, 32(5):972-983. 10.1016/j.neubiorev.2008.03.009, 18471878.
63. Watkins LR, Martin D, Ulrich P, Tracey KJ, Maier SF. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 1997, 71(3):225-235. 10.1016/S0304-3959(97)03369-1, 9231865.
64. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995, 9(9):726-735.
65. Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999, 79(1):143-180.
66. Lim EJ, Jeon HJ, Yang GY, Lee MK, Ju JS, Han SR, Ahn DK. Intracisternal administration of mitogen-activated protein kinase inhibitors reduced mechanical allodynia following chronic constriction injury of infraorbital nerve in rats. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(6):1322-1329. 10.1016/j.pnpbp.2007.05.016, 17618720.
67. Cruz CD, Neto FL, Castro-Lopes J, McMahon SB, Cruz F. Inhibition of ERK phosphorylation decreases nociceptive behaviour in monoarthritic rats. Pain 2005, 116(3):411-419. 10.1016/j.pain.2005.05.031, 15979799.
68. Lee Y, Pai M, Brederson JD, Wilcox D, Hsieh G, Jarvis MF, Bitner RS. Monosodium iodoacetate-induced joint pain is associated with increased phosphorylation of mitogen activated protein kinases in the rat spinal cord. Mol Pain 2011, 7:39. 10.1186/1744-8069-7-39, 3120677, 21599960.
69. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16(2):109-110. 10.1016/0304-3959(83)90201-4, 6877845.
70. Fagan SC, Edwards DJ, Borlongan CV, Xu L, Arora A, Feuerstein G, Hess DC. Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection. Exp Neurol 2004, 186(2):248-251. 10.1016/j.expneurol.2003.12.006, 15026261.
71. Paxinos G. The Rat Nervous Syste. 1995, Philadelphia: Elsevier Elsevier.
72. Mestre C, Pélissier T, Fialip J, Wilcox G, Eschalier A. A method to perform direct transcutaneous intrathecal injection in rats. J Pharmacol Toxicol Methods 1994, 32(4):197-200. 10.1016/1056-8719(94)90087-6, 7881133.